Crossmark

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression

Crossref DOI link: https://doi.org/10.1186/s13046-018-0809-0

Published Online: 2018-07-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Jian

Chang, Kun

Peng, Jingtao

Shi, Qing

Gan, Hualei

Gao, Kun

Feng, Kai

Xu, Fujiang

Zhang, Hailiang

Dai, Bo

Zhu, Yao

Shi, Guohai

Shen, Yijun

Zhu, Yiping

Qin, Xiaojian

Li, Yao

Zhang, Pingzhao

Ye, Dingwei

Wang, Chenji
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81472377, 81672558, 81201533, 1400753)

National Natural Science Foundation of China (81672544)
License Information

Text and Data Mining valid from 2018-07-11
More Information

Article History

Received: 5 February 2018

Accepted: 25 June 2018

First Online: 11 July 2018

Ethics approval and consent to participate

: The study was approved by the ethics committee of the Fudan University Shanghai Cancer Center and signed informed consent was obtained from each patient.

: All the authors have read and approved the manuscript.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.